bimagrumab and semaglutide 60% HFD Induced Obesity (DIO) _GemPharmatech

Combination GLP-1 Therapy Shows Fat Mass Loss While Preserving Lean Mass in Adults with Obesity

26.21

★★★★☆4.8 (126)

💪 Lose fat, keep the muscle! The BELIEVE Phase 2 trial shows that combining Bimagrumab with Semaglutide leads to 17.8 kg weight loss while preserving lean mass. A game-changer for healthy, sustainable

25.61

★★★★★4.9 (98)

Bimagrumab and semaglutide combo enhances weight loss: Study

24.12

★★★★★5.0 (157)

New drugs for the treatment of obesity: do we need approaches to preserve muscle mass? | Reviews in Endocrine and Metabolic Disorders

26.08

★★★★★4.7 (84)

This may be where obesity medicine is heading next: not just weight loss, but better body composition. A new phase 2 Nature Medicine paper studied semaglutide plus bimagrumab in adults with obesity

22.35

★★★★★4.9 (203)

Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism

24.82

★★★★★5.0 (176)

The science of losing fat while keeping muscle just got a lot more interesting. GLP-1 drugs like semaglutide have transformed obesity medicine. But they come with a problem that doesn't get enough

25.76

★★★★★4.8 (132)